Suchergebnisse - "Infantino, Maria"

PubPharm (214)

31

Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity : An Italian study

enthalten in: Journal of medical virology | 2022

von Infantino, M. | Manfredi, M. | Alessio, M. | +13

32

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis : A prospective multicenter longitudinal study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Farroni, C. | Aiello, A. | Picchianti-Diamanti, A. | +31

33

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis : suPAR as a Biomarker in the Light of a Personalized Medicine Perspective

enthalten in: Journal of personalized medicine | 2022

von Benucci, M. | Damiani, A. | Russo, E. | +7

34

An Italian Multicenter Study on Anti-NXP2 Antibodies : Clinical and Serological Associations

enthalten in: Clinical reviews in allergy & immunology | 2022

von Fredi, M. | Cavazzana, I. | Ceribelli, A. | +36

35

Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine

enthalten in: International journal of molecular sciences | 2022

von Infantino, M. | Tsalouchos, A. | Russo, E. | +10

36

Cardiovascular safety, cancer and Jak-inhibitors : Differences to be highlighted

enthalten in: Pharmacological research | 2022

von Benucci, M. | Damiani, A. | Infantino, M. | +5

37

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity : an Italian experience

enthalten in: Clinical immunology (Orlando, Fla.) | 2022

von Infantino, M. | Morena, L. | Di Pietro, M. | +16

38

Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis

enthalten in: Immunologic research | 2022

von Benucci, M. | Damiani, A. | Gobbi, F. | +4

39

Current technologies for anti-ENA antibody detection : State-of-the-art of diagnostic immunoassays

enthalten in: Journal of immunological methods | 2022

von Infantino, M. | Carbone, T. | Brusca, I. | +20

40

Predicting Loss of Efficacy after Non-Medical Switching : Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

enthalten in: Journal of personalized medicine | 2022

von Benucci, M. | Damiani, A. | Russo, E. | +5

ErratumIn: J Pers Med. 2023 Jan 18;13(2):. - PMID 36836609